Werner ME, Meredith AL, Aldrich RW, Nelson MT. Hypercontractility and impaired sildenafil relaxations in the BK Ca channel deletion model of erectile dysfunction. Am J Physiol Regul Integr Comp Physiol 295: R181-R188, 2008. First published May 14, 2008 doi:10.1152/ajpregu.00173.2008.-Erectile dysfunction (ED) can be elicited by a variety of pathogenic factors, particularly impaired formation of and responsiveness to nitric oxide (NO) and the downstream effectors soluble guanylate cyclase (sGC) and cGMP-dependent protein kinase I (PKGI). One important target of PKGI in smooth muscle is the large-conductance, Ca 2ϩ -activated potassium (BKCa) channel. In our previous report (42), we demonstrated that deletion of the BK Ca channel in mice induced force oscillations and led to reduced nerve-evoked relaxations and ED. In the current study, we used this ED model to explore the role of the BK Ca channel in the NO/sGC/PKGI pathway. Electrical field stimulation (EFS)-induced contractions of corpus cavernosum smooth muscle strips were significantly enhanced in the absence of BK Ca channel function. In strips precontracted with phenylephrine, EFS-induced relaxations were converted to contractions by inhibition of sGC, and this was further enhanced by loss of BK channel function. Sildenafil-induced relaxations were decreased to a similar extent by inhibition of sGC or BK Ca channels. At concentrations Ͼ1 M, sildenafil caused relaxations independent of inhibition of sGC or BK Ca channels. Sildenafil did not affect the enhanced force oscillations that were induced by the loss of BK Ca channel function. Yet, these oscillations could be completely eliminated by blocking L-type voltage-dependent Ca 2ϩ channels (VDCCs). These results suggest that therapeutically relevant concentrations of sildenafil act through cGMP and BK Ca channels, and loss of BKCa channel function leads to hypercontractility, which depends on VDCCs and cannot be modified by the cGMP pathway. smooth muscle; calcium-activated potassium channel; mouse ERECTILE DYSFUNCTION (ED) is described as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance (44). It affects 30 million men in the United States (5), and its prevalence increases with age and diseases like diabetes and hypertension (4,24,31). Erectile function and a proper penile erection occurs in response to nerve stimulation and the release of nitric oxide (NO) from parasympathetic nonadrenergic-noncholinergic (NANC) nerves as well as from the vascular endothelium (2,13,16,27). In mice, the NO-producing enzyme NO synthase has been found in the dorsal penile nerve and its branches in the mouse penis (9) as well as in intrinsic nerves of the erectile tissue (14). The majority of NO effects are mediated through the soluble guanylate cyclase (sGC) and its product, cGMP (2,8,16,33). cGMP acts as a modifying agent on ion channels, phosphodiesterases, and protein kinases (19). One of the protein kinases, the cGMP-dependent protein kinase I (PKGI), phosphorylat...